Our Comprehensive Genomic Test analyses key genetic markers related to:
LONGEVITY FOR ALL
This test is ideal for:
- Individuals seeking to optimise long-term health and enhance healthy ageing
- Those with a family history of inherited or genetic conditions
- Proactive health seekers and biohackers looking for personalised genetic insights
- Athletes and fitness enthusiasts aiming to maximise performance and recovery based on their genetic profile
Health Risk Screening
Analysis of genes associated with increased risks for various diseases, including cardiovascular diseases, cancers, endocrine disorders, neurological disorders, and immune-related conditions.
Carrier Screening
Identification of carrier status for numerous recessive genetic conditions, enabling better-informed family planning and reproductive health decisions.
Pharmacogenetic Profiling (PGx)
Assessment of gene-drug interactions to guide medication choices and dosages, minimising adverse effects and maximising drug effectiveness.
Disease Group Risk Assessment
Detection of genetic variants linked to multiple disease groups, including cardiovascular, endocrine, hematologic, mitochondrial, neurological, immune system, cancer syndromes, and miscellaneous rare conditions.
Organ Health Genetic Markers
Screening for inherited risks affecting organs such as the heart, liver, kidneys, and lungs, to enable early monitoring and intervention strategies.
Inherited Cancer Syndromes Screening
Identification of mutations in genes associated with hereditary cancer risks, such as BRCA1/2-related breast and ovarian cancer, Lynch syndrome, and others.
Syndromic Disease Insights
Detection of syndromic genetic conditions affecting multiple organ systems, supporting early diagnosis and multi-disciplinary management planning.
Rare Disease Discovery
Comprehensive analysis for rare and ultra-rare conditions often missed by standard panels, using whole genome sequencing depth.
What’s Included in Your Genomic Test Report?
Hypertension, coronary artery disease, cardiomyopathies, arrhythmias, aortic aneurysm, familial hypercholesterolemia.
Type 1 diabetes, Type 2 diabetes, maturity onset diabetes of the young (MODY), hypothyroidism, hyperthyroidism, obesity-related genetic predisposition, adrenal hyperplasia.
Sickle cell anaemia, beta-thalassaemia, alpha-thalassaemia, hereditary haemochromatosis, haemophilia A, haemophilia B, hereditary thrombophilia (Factor V Leiden mutation).
Alzheimer's disease, Parkinson’s disease, epilepsy, multiple sclerosis, motor neurone disease (MND/ALS), Charcot-Marie-Tooth disease.
Common variable immunodeficiency (CVID), autoimmune thyroid disease, systemic lupus erythematosus (SLE), coeliac disease, Type 1 diabetes (autoimmune form).
BRCA1/BRCA2-associated breast and ovarian cancer, Lynch syndrome (colorectal cancer), Li-Fraumeni syndrome, familial adenomatous polyposis, melanoma predisposition, multiple endocrine neoplasia types 1 and 2.
MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes), MERRF syndrome (myoclonic epilepsy with ragged red fibres), Leigh syndrome, mitochondrial DNA depletion syndromes.
Polycystic kidney disease, cystic fibrosis (CFTR mutations), alpha-1 antitrypsin deficiency (liver and lung risk), Wilson’s disease (copper metabolism disorder).
Rhizomelic chondrodysplasia punctata, sarcoidosis susceptibility, Marfan syndrome, familial focal epilepsy, peroxisome biogenesis disorders, and other rare genetic conditions.
Marfan syndrome, Ehlers-Danlos syndrome, Noonan syndrome, Williams syndrome, microcephaly syndromes, congenital malformation syndromes.
Gene-drug interaction analysis for:
Warfarin (anticoagulation), Clopidogrel (antiplatelet therapy), Statins (cholesterol management), Methotrexate (autoimmune treatment), Ondansetron (anti-sickness medication), Salmeterol (asthma treatment)
Cystic fibrosis (CFTR gene), Tay-Sachs disease (HEXA gene), spinal muscular atrophy (SMN1 gene), sickle cell anaemia (HBB gene), thalassaemia (HBA1, HBA2 genes), Fragile X syndrome (FMR1 gene), and others.
Genetic influences on nutrient absorption (e.g., vitamin D, folate, iron), metabolism efficiency (e.g., caffeine metabolism, lactose intolerance), body weight regulation, and fitness response to exercise.
Genetic markers linked to traits such as extraversion, neuroticism, conscientiousness, cognitive performance, snacking behaviour, and impulsivity.
Variants associated with extreme longevity, healthy ageing, and reduced risk of age-related diseases.
Related Products
-
Sold outSports Performance Test
Regular price £190.00 GBPRegular priceUnit price per -
Sold outNewborn Screening Test
Regular price £300.00 GBPRegular priceUnit price per
